secwatch.observer — SEC 8-K summary
======================================

Issuer:     ANI PHARMACEUTICALS INC (ANIP)
CIK:        0001023024
Form:       8-K
Filed at:   2023-08-23T23:59:59+00:00
Accession:  0001104659-23-094371
Event type: leadership
Sentiment:  positive
Materiality: 0.35
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ANI Pharma appoints Matt Leonard to board; Nash not to seek reelection
----------------------------------------------------------------------

- Board appointed Matt Leonard as director, effective August 21, 2023, with term expiring at 2024 annual meeting.
- Leonard is Chief Pharmacy Strategy Officer at Capsule; previously held senior roles at CVS Health and Covetrus.
- Leonard receives initial restricted stock award of $435,000 vesting over three years under the 2022 Stock Incentive Plan.
- David B. Nash will not seek reelection at the 2024 annual meeting; continues as director until then.
- Nash's decision not due to any disagreement with the company on operations, policies, or practices.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/0001104659-23-094371-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1023024/000110465923094371/tm2324374d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-23-094371

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer